Kaposi sarcoma in South African children

Pediatric Blood and Cancer

Volumn 56, Issue 3, 2011, Pages 392-396

  Stefan, D Cristina ^a   Stones, David K ^b   Wainwright, Linda ^c   Newton, Robert ^d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Africa; Cancer; Children; HIV; Kaposi

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; CANCER REGISTRY; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SKIN DEFECT; SOUTH AFRICA; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CD4 LYMPHOCYTE COUNT; CHILD; COHORT STUDIES; DOXORUBICIN; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI; SOUTH AFRICA; SURVIVAL RATE; VINBLASTINE; VINCRISTINE; VIRAL LOAD; YOUNG ADULT;

EID: 78651075255     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22903     Document Type: Article

References (23)

1. Kaposi M. Idiopathic multiple pigmented sarcoma of the skin. CA Cancer J Clin 1982; 32: 342-347 (English translation of the original article from 1872).
2. Sissolak G, Mayaud P. AIDS-Related Kaposi sarcoma: Epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa. Tropical Med Int Health 2005; 10: 981-992.
3. Sitas F, Newton R. Kaposi's sarcoma in South Africa. J Natl Cancer Inst Monogr 2000; 28: 1-4.
4. Gottlieb GJ, Ragaz A, Vogel JV, et al. A preliminary communication on extensively disseminated Kaposi's sarcoma in young homosexual men. Am J Dermatopathol 1981; 3: 111-114.
5. Stein L, Urban MI, O'Connell D, et al. The spectrum of human immunodeficiency-associated cancers in a South African black population: Results from a case-control study, 1995-2004. Int J Cancer 2008; 122: 2260-2265.
6. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.
7. Malope BI, Pfeiffer RM, Mbisa G, et al. Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population. J Acquir Immune Defic Syndr 2007; 44: 351-355.
8. Ferrand RA, Corbetta EL, Woodd R, et al. AIDS among older children and adolescents in Southern Africa: Projecting the time course and magnitude of the epidemic. AIDS 2009; 23: 2039-2046.
9. HSRC, MRC. South African national HIV prevalence, incidence, behaviour and communication survey, 2008. Cape Town: HSRC Press; 2009. p xvii.
10. Ziegler JL, Katongole-Mbidde E. Kaposi's sarcoma in childhood: Ana analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer 1996; 65: 200-203.
11. Olweni CLM, Kaddumukasa A, Atine I, et al. Kaposi's sarcoma: Clinical features and therapy. Br J Cancer 1976; 33: 555-560.
12. Sinfield RL, Molyneux EM, Banda K, et al. Spectrum and presentation of pediatric malignancies in the HIV era: Experience from Blantyre, Malawi, 1998-2003. Pediatr Blood Cancer 2007; 48: 515-520.
13. Cairncross LL, Davidson A, Millar AJW, et al. Kaposi sarcoma in children with HIV: A clinical series from Red Cross Children's Hospital. J Pediatr Surg 2009; 44: 373-376.
14. Gantt S, Kakuru A, Wald A, et al. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer 2010; 54: 670-674.
15. Mitsuyasu RT. Clinical variants and staging of Kaposi's sarcoma. Semin Oncol 1987; 14: 13-18.
16. Athale UH, Patil PS, Chintu C, et al. Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 96-100.
17. Kankasa C, Carter RJ, Briggs N, et al. Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: Acceptability and feasibility. J Acquir Immune Defic Syndr 2009; 51: 202-208.
18. Klaskala W, Brayfield BP, Kankasa C, et al. Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia. J Med Virol 2005; 75: 93-100.
19. Arkin LM, Cox CM, Kovarik CL. Kaposi's sarcoma in the pediatric population. The critical need for tissue diagnosis. Pediatr Infect Dis J 2009; 28: 426-428.
20. Callens SFJ, Kitetele F, Lusiama JS, et al. Computed CD4 percentages, a low-cost method for determining pediatric antiretroviral treatment eligibility. BMC Inf Dis 2008; 8: 31.
21. 3. J Int Assoc Physicians AIDS Care (Chic Ill) 2009; 8: 279-285 [Epub August 31, 2009].
22. Martellotta F, Berretta M, Vaccher E, et al. AIDS-related Kaposi's sarcoma: State of the art and therapeutic strategies. Curr HIV Res 2009; 7: 634-638.
23. Udhrain A, Skubitz MK, Northfelt DW. Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi sarcoma. Int J Nanomedicine 2007; 2: 345-352.